How a specialized Masters Degree can boost your healthcare career!

Are you searching for that opportunity to help propel you to the next promotion? Add to your credentials so you stay relevant? Give you the tools to effect change in healthcare in a new way?

If so, you may be interested in the well-respected Online MS+MBA and Certificate Programs in Applied PharmacoEconomics or Managed Care Systems at the University of Florida.

 

 

Designed specifically for working professionals, you can pursue this degree and continue to work full-time, manage your family commitments, and travel for work or pleasure.

Here’s what a former graduate of UF’s Online Applied Pharmacoeconomics Program had to say:

“The course load, timing of exams, and amount of assignments worked well with my other responsibilities and it wasn’t too burdensome. This was really important.” ~Former graduate student, now Manager, GHEOR at Xcenda

This program is different than most online graduate programs. Open to anyone with a B.S. (or higher) degree, students in UF’s program come from all walks of life, many with diverse and varied experience: PharmDs, RNs, MDs, HOLs/MSls, and non-healthcare backgrounds, as well. In fact, about one-quarter of students come from business or legal backgrounds and recognize the importance of applied skills in healthcare systems, one of the greatest growth areas of the future! No prior healthcare experience required!

Choose from MS, MS+MBA, or Graduate Certificate Program. And focus on your area of interest, with 4 Specialty Tracks:

The classes are focused on developing real-world, applied skills in critical growth areas of the 21st century: managed care systems, health economics, outcomes research, patient safety, or pharmaceutical regulation. Blending strong academic training with pragmatic skills leads to a graduate who is ready to implement change immediately. Other graduates note that this online MS program helped to fast-track their career and increased their chance of promotion.

“I got a great foundation across many areas of healthcare, including policy, ethics, epidemiology, data analytics, and economics. I learned things in my classes that immediately helped me in my job – even before graduating! ~Former Graduate Student, now Director, Clinical Program Management at major PBM

Online, but interactive!

At UF’s Online Graduate Program in Pharmaceutical Outcomes and Policy, you won’t be stuck learning on your own with a dis-embodied voice and a PPT presentation! In an innovative, time-tested, and highly rated format called “Live Online Learning”, students in the online graduate program learn in a teacher-led once weekly class attended by you and all your fellow students. For about two hours on Sunday nights, you gather online to listen to a live lecture, ask questions, network, and problem-solve – together. So, you get the advantage of online learning, where you can “attend” class from anywhere (your home, in your PJs, or the airport while on a business trip). But, you also get the advantage of interactive learning as if you are in a classroom – albeit a “virtual classroom”.

Don’t take our word for it. Here’s what other students say about the Live Online Learning in the UF Online Pharmaceutical Outcomes & Policy Graduate Program:

“I had taken online classes before that had no live component to them, and you just play it back on-demand. I found it really hard if you have questions. You can’t raise your hand (like you can in our live online classes), and interaction with classmates was invaluable, particularly for me because I didn’t have a healthcare background.” ~JB, Managed Market Account Manager for a large pharmaceutical manufacturer.

Are you worried that you might have trouble balancing your work and home life commitments with a weekly online class?

Don’t be. One of the tenets of the UF Online POP program is flexibility and manageability.  All of your fellow students are in the same boat, and the Professors are focused on working with you and your needs, no matter how unique.

“This program really met my needs for workload and offered important flexibility when I started a new job. I was able to take a semester off to move and get into my new position, then restart the program. ~DG, PharmD, MS, MBA, Director at a major healthcare insurance company

 

Apply now! Click here to get started.

 

Not quite ready to commit? Then, join us for an Informational Webinar, on Thursday, March 1, 2018 from 12:30-1:30pm EST.

Register for Online Career Fair for HEOR & Market Access

 

In this webinar, you will hear from Dr. Robert Navarro, Track Directory of Managed Care Systems at UF and Heather Steingraber, Assistant Director of Online Graduate Programs in Pharmaceutical Outcomes and Policy.

  • Program overview
  • Who can apply? No prior healthcare experience required!
  • 4 specialty learning tracks + joint MBA or Graduate Certificate options
    • Applied PharmacoEconomics
    • Managed Care Pharmacy Systems
    • Patient Safety
    • Pharmaceutical Regulation
  • Application process and deadlines
  • Unique online interactive learning
  • Alumni insights: Career options after you graduate
  • Costs

 

What are you waiting for? All you need is a desire to improve yourself & healthcare. 

, , , , , , , , ,

No Comments

Who Are the Real Change-Agents in Pharma Market Access? The Growing Role of Value Demonstration

Would you believe it if I said that in a few years, the term “HEOR” may go the way of man-buns and flip phones?

While the man-bun joke about the terminology may be a slight exaggeration, our field is indeed undergoing a notable change and we are leaving some old approaches behind. We will talk about these changes in HEOR in an interactive, live-streaming Fireside Chat with a Panel of leading industry executives from Pfizer, Teva, Oxford PharmaGenesis, and HealthEconomics.Com:

[WebinarThe Changing Face of Careers in HEOR & Value Demonstration: Fireside Chat with Pharma and Communications Agency Executives

February 22, 11am-12noon EST

Fortunately for you (and us), the science of HEOR (and its commercialization counterpart, Market Access [MA]) will likely remain highly relevant and continue to grow; however, the way we are applying it is evolving into “Value Demonstration”, and it is much more customer-centric.  This change is more than just semantics, or at least many of us think so.

Value Demonstration Tools

 

Value Demonstration refers to tailored evidence-gathering solutions that demonstrate the clinical and economic impact of products on patients and health systems, while linking outcomes to quality measures, all of which are strategically incorporated into product life cycle planning.

We are moving away from a brand, volume, and narrow clinical focus of pharmaceutical interventions, and broadening our scope to real world evidence that has a broader end-customer perspective based on their definition of value.

Are you and our industry adequately prepared for this new role?

Perhaps, but it will take Organizational Transformation.

The change to Value Demonstration and Real-World Evidence is playing out in all corners of the healthcare ecosystem. In a study of HEOR professionals conducted by HealthEconomics.Com, 90% of Biopharma and more than 80% of Consulting professionals say that market demand for RWE is increasing. Departmental siloeing is an albatross, and there are herculean efforts to work at an enterprise level and focus on the customer.

Simultaneously, many Pharma/Life Sciences, Consultancy/CROs, and Scientific Communication Agencies are showing growth in Medical Affairs and Payer Evidence/Patient Access commercialization departments. These groups are gaining clarity in their responsibility for RWE, Value Demonstration, Information Strategy & Data Analytics, and Value Translation.

Change brings opportunity (and challenges).

This change to Value Demonstration is an opportunity. An opportunity to positively impact the healthcare system and patients, an opportunity for innovative business models, and an opportunity for employees to bring new and needed skill sets to their organization.

According to the most recent Global Salary Survey for HEOR & Market Access of 500 industry professionals conducted by HealthEconomics.Com, the percentage of respondents who identify Value/Market Access as their main job grew by 20% in the past two years, while those that specifically identified HEOR as their main job function decreased by 24%!  Other job functions that grew in 2017 (vs 2015) were Pricing and Reimbursement (three-fold increase) and HEOR/Value-focused Medical Communication (two-fold growth).

Respondent-reported Job Function, 2017 vs 2015 Global Salary Survey

 

In addition to organization level changes, skill sets of employees are changing. In this same Global Salary Survey, we asked about the top 3 things to change about HEOR/MA. As shown in the figure below, involvement of HEOR in the early development phase and less separation of HEOR/Market Access from other departments were the main areas that needed the most change in our industry. Moreover, HEOR professionals expressed the need for additional cross-departmental/functional opportunities, more time with customers, and the need for more business experience (as opposed to technical) to establish better links between HEOR and other industry functions and customers.

 

Areas of Needed Change in HEOR/MA, Global Salary Survey, % responding

 

These issues related to strategic focus, organizational change, and skill sets for those involved in HEOR and Value Demonstration are pivotal. We, as an industry, need to develop strategies to address the pressing concerns in industry careers and job responsibilities of HEOR & Market Access professionals.  Register now for the collaborative February 22 webinar:

 

Led by Dr. Patti Peeples, CEO at HealthEconomics.Com and Dr. Richard White, Commercial Director at Oxford PharmaGenesis, along with industry expert Paenlists Dr. Riad Dirani, VP of Global HEOR, Teva, and Danielle Bargo, Director, HEOR (Gastroenterology), Pfizer, we will discuss:

  • Trends in modern Value Evidence Job functions
  • Staffing and training to develop employees to successfully manage new customer demands
  • Trends in Compensation (Salary, Benefits, Bonuses) for HEOR, Market Access, and Value Demonstration
  • A case study of new skill sets essential for Value Demonstration/Medical Affairs
  • Salary trends derived from the 2017 HEOR & Market Access Salary Survey
  • Substantial Q&A between Audience and Panelists

Drop us a note if you have issues you would like to see addressed in our webinar, or thoughts about this blog post.  See you on February 22nd!


Written by:

Ankit Shah, MS, BS Pharm, Contributing Writer

Patti Peeples, RPh, PhD, CEO of HealthEconomics.Com

, , , ,

No Comments